Features of OLIG2 modules (Figs 4-6) are also consistent across GBM and LGG and diametrically opposed to those of STAT3, AHR, and CCR2. In both GBM and LGG, higher expression is associated with a higher proportion of nonenhancing tumor and lower proportion of enhancing tumor. The gene discussed is CCR2; the disease is glioblastoma.